Form 4: Elanco Executive Ellen de Brabander Reports Stock Transactions

Ellen de Brabander, an Executive Vice President at Elanco Animal Health Inc, reported the acquisition and disposal of company stock on February 19, 2025.

Summary

• On February 19, 2025, Ellen de Brabander, Executive Vice President of Innovation and Regulatory Affairs at Elanco Animal Health Inc, reported transactions involving the company's common stock.
• De Brabander acquired 141,244 shares of common stock at $0.
• She also disposed of 69,916 shares at a price of $11.24.
• Following these transactions, de Brabander directly owns 186,214 shares of Elanco common stock.
• The transactions were reported on a Form 4 filing with the SEC.
• A power of attorney was granted on May 14, 2024, authorizing certain individuals to act on de Brabander's behalf for SEC filings.

Sentiment

Score: 5

Explanation: This is a neutral report of stock transactions, with no inherent positive or negative sentiment. It simply reflects the activity of an executive.

Industry Context

This is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies. It provides transparency to investors regarding insider activity.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider transactions.
• Similar filings are made by executives at companies like Zoetis and Merck Animal Health, providing insights into their stock ownership and trading activities.

Stakeholder Impact

• The reported transactions provide shareholders with information about insider trading activity, which can influence investor sentiment.

Key Dates

Keywords

Elanco Animal Health, Ellen de Brabander, stock transaction, Form 4, SEC filing, common stock, power of attorney